Danaher Corp.
- DHR ยท NYSE
- Industrial Instruments For Measurement, Display, and Control
- Washington, DC
- 60,000 employees
- CIK 0000313616
Updated from SEC filings through
Top things to know
Executives
-
Julie Sawyer Montgomery President and Chief Executive Officer 8-K, 2026-10-20 - Rainer Blair President & CEO 4, 2026-08-24
- Matthew E. Gugino EVP & Chief Financial Officer 4, 2026-08-06
- Matthew Gugino Chief Financial Officer 8-K, 2026-08-03
- Matthew R. Mcgrew Executive Vice President and Chief Financial Officer 10-K, 2026-02-24
- Heathre T. Moler SVP, Chief HR Officer 3, 2026-10-02
What leadership is saying
“We delivered better-than-expected third quarter revenue, earnings and cash flow, and are encouraged by the improving trends we saw across our end markets. The continued acceleration in core revenue growth excluding respiratory revenue, together with DBS-driven execution drove double-digit adjusted EPS growth and underscored our ability to convert improving demand into strong financial performance”
Earnings press release (8-K Ex. 99.1), filed October 20, 2026
Danaher Corp is a U.S. public company in industrial instruments for measurement, display, and control (SIC 3823), headquartered in Washington, DC. It trades as DHR on NYSE. Revenue was $24.6B in the fiscal year ending December 31, 2025, +2.9% from the year before. It reported about 60,000 employees. Julie Sawyer Montgomery is President and Chief Executive Officer.
Five-year financials
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $24.6B 10-K, 2026-02-24 | $23.9B 10-K, 2026-02-24 | $23.9B 10-K, 2026-02-24 | $26.6B 10-K, 2025-02-20 | $24.8B 10-K, 2024-02-21 |
| Operating income | $4.7B 10-K, 2026-02-24 | $4.9B 10-K, 2026-02-24 | $5.2B 10-K, 2026-02-24 | $7.5B 10-K, 2025-02-20 | $6.4B 10-K, 2024-02-21 |
| SG&A | $8.2B 10-K, 2026-02-24 | $7.8B 10-K, 2026-02-24 | $7.3B 10-K, 2026-02-24 | $7.1B 10-K, 2025-02-20 | $6.8B 10-K, 2024-02-21 |
| Net income | $3.6B 10-K, 2026-02-24 | $3.9B 10-K, 2026-02-24 | $4.8B 10-K, 2026-02-24 | $7.2B 10-K, 2025-02-20 | $6.4B 10-K, 2024-02-21 |
Annual figures from XBRL in each company's own filings. Click a figure to open the filing. SG&A marked derived is general and administrative plus selling and marketing.
Leadership and board
| Name | Title | Source |
|---|---|---|
| Julie Sawyer Montgomery President & Chief Executive Officer, Danaher | President and Chief Executive Officer | 8-K, 2026-10-20 |
| Rainer Blair | President & CEO | 4, 2026-08-24 |
| Feroz Dewan | Board member (per proxy) bio: Chief Executive Officer | DEF 14A, 2026-03-25 |
| Raymond C. Stevens, PhD | Board member (per proxy) bio: Chief Executive Officer | DEF 14A, 2026-03-25 |
| Matthew E. Gugino | EVP & Chief Financial Officer | 4, 2026-08-06 |
| Matthew Gugino | Chief Financial Officer | 8-K, 2026-08-03 |
| Teri L. List | Board member (per proxy) bio: Former Executive Vice President and Chief Financial Officer | DEF 14A, 2026-03-25 |
| Matthew R. Mcgrew | Executive Vice President and Chief Financial Officer | 10-K, 2026-02-24 |
| Heathre T. Moler | SVP, Chief HR Officer | 3, 2026-10-02 |
| Shashanka Muppaneni | SVP, Chief Strategy Officer | 3, 2026-10-02 |
| Christopher Bouda V.P. Chief Accounting Officer at Danaher Corporation | VP, Chief Accounting Officer | 4, 2026-08-06 |
 Gregory M. Milosevich | Executive Vice President | 4, 2026-08-06 |
 Jonathan Leiken Chief Legal Officer, Danaher Corporation | SVP-Chief Legal Officer | 4, 2026-08-06 |
 Jose-Carlos Gutierrez-Ramos | SVP, Chief Science Officer | 4, 2026-08-06 |
| Christopher Paul Riley | Executive Vice President | 4, 2026-08-06 |
| Montgomery Julie A. Sawyer | Executive Vice President | 4, 2026-08-06 |
What Danaher Corp does
Danaher is a global science and technology innovator committed to accelerating the power of science and technology to improve human health. Danaher is comprised of more than 15 operating companies with leadership positions in the biotechnology, life sciences and diagnostics sectors, organized under three segments (Biotechnology, Life Sciences and Diagnostics).
Item 1. Business, 10-K for the year ending December 31, 2025
Shares and governance
| Shares outstanding | 703.5 million (as of October 15, 2026) | 10-Q, October 21, 2026 |
|---|---|---|
| Public float | $126B (as of June 30, 2025) | 10-K, February 24, 2026 |
| Reportable segments | 3 (period ending September 25, 2026) | 10-Q, October 21, 2026 |
| Latest proxy statement | Meeting May 5, 2026 (filed March 25, 2026) | DEF 14A, March 25, 2026 |
| Auditor | Ernst & Young LLP (Tysons, Virginia) | Latest 10-K |
Insider trades
Open-market buys and sales by officers and directors, from Forms 4 and 5. One row per filing.
| Date | Insider | Trade | Shares | Value | Source |
|---|---|---|---|---|---|
| October 28, 2026 | Christopher Bouda VP, Chief Accounting Officer | Sale | 7,598 | $1.8M | Form 4, October 29, 2026 |
| October 28, 2026 | Matthew McGrew Executive Vice President | Sale | 29,754 | $7.0M | Form 4, October 29, 2026 |
| August 21, 2026 | Rainer Blair President & CEO | Sale | 58,255 | $12.7M | Form 4, August 24, 2026 |
| May 1, 2026 | Alan G. Spoon Director | Sale | 1,358 | $237K | Form 4, May 4, 2026 |
| February 19, 2026 | Gregory M. Milosevich Executive Vice President | Sale | 1,320 | $275K | Form 4, February 20, 2026 |
| November 25, 2025 | Mitchell P. Rales Chairman of Exec. Committee | Sale | 40,625 | $9.4M | Form 4, November 26, 2025 |
| November 18, 2025 | Teri List Director | Sale | 3,298 | $747K | Form 4, November 19, 2025 |
| November 12, 2025 | Mitchell P. Rales Chairman of Exec. Committee | Sale | 437,000 | $95.6M | Form 4, November 13, 2025 |
Recent 8-K events
- 8-K filed 2026-10-21
- Item 2.02 Results of operations and financial condition (earnings release)
- 8-K filed 2026-10-13
- Item 5.02 Departure or appointment of directors or officers; compensation
- Item 8.01 Other events
- 8-K filed 2026-08-03
- Item 5.02 Departure or appointment of directors or officers; compensation
- Item 7.01 Regulation FD disclosure
- Item 8.01 Other events
- 8-K filed 2026-07-21
- Item 2.02 Results of operations and financial condition (earnings release)
- 8-K filed 2026-06-03
- Item 2.03 Creation of a direct financial obligation
- Item 8.01 Other events
- 8-K filed 2026-05-07
- Item 5.02 Departure or appointment of directors or officers; compensation
- Item 5.07 Submission of matters to a vote of security holders
- 8-K filed 2026-04-29
- Item 1.01 Entry into a material definitive agreement
- Item 8.01 Other events
- 8-K filed 2026-04-21
- Item 2.02 Results of operations and financial condition (earnings release)
- 8-K filed 2026-04-17
- Item 1.01 Entry into a material definitive agreement
- Item 2.03 Creation of a direct financial obligation
- 8-K filed 2026-02-17
- Item 8.01 Other events
Frequently asked questions about Danaher Corp
- What does Danaher Corp do?
- In its own words, from Item 1 of its 10-K: "Danaher is a global science and technology innovator committed to accelerating the power of science and technology to improve human health. Danaher is comprised of more than 15 operating companies with leadership positions in the biotechnology, life sciences and diagnostics sectors, organized under three segments (Biotechnology, Life Sciences and Diagnostics)."
- What is Danaher Corp's revenue?
- $24.6B for the fiscal year ending December 31, 2025, from its 10-K filed February 24, 2026.
- Is Danaher Corp profitable?
- Danaher Corp reported net income of $3.6B for the fiscal year ending December 31, 2025.
- How many employees does Danaher Corp have?
- About 60,000 as of December 31, 2025, as stated in its annual report.
- Who is the CEO of Danaher Corp?
- Julie Sawyer Montgomery, President and Chief Executive Officer, as named in a 8-K filed October 20, 2026.
- Who is the CFO of Danaher Corp?
- Matthew E. Gugino, EVP & Chief Financial Officer, as named in a 4 filed August 6, 2026.
- Where is Danaher Corp headquartered?
- Washington, DC.
- What is Danaher Corp's stock ticker?
- DHR on NYSE.
- What industry is Danaher Corp in?
- Industrial Instruments For Measurement, Display, and Control, SIC code 3823.
- What is Danaher Corp's website?
- danaher.com. Investor relations: https://investors.danaher.com/.
- When does Danaher Corp report earnings next?
- January 20, 2027. Source: estimate_8k_pattern.
- Is Danaher Corp a public company?
- Yes. Danaher Corp files with the SEC under CIK 0000313616 and trades as DHR.
- Who audits Danaher Corp?
- Ernst & Young LLP, Tysons, Virginia, as named in its latest annual report (10-K).
- How many shares of Danaher Corp are outstanding?
- 703.5 million shares as of October 15, 2026, from its 10-Q filed October 21, 2026.
- What is Danaher Corp's public float?
- $126B as of June 30, 2025, as reported on the cover of its 10-K filed February 24, 2026.
- How many business segments does Danaher Corp report?
- 3 reportable segments for the period ending September 25, 2026, from its 10-Q filed October 21, 2026.
- When is Danaher Corp's annual shareholder meeting?
- May 5, 2026, per its proxy statement (DEF 14A) filed March 25, 2026.
- Have Danaher Corp insiders traded stock recently?
- Since August 22, 2025, officers and directors reported 13 open-market sales worth about $267M and 0 purchases on Forms 4 and 5. The most recent: Christopher Bouda (VP, Chief Accounting Officer) sold 7,598 shares on October 28, 2026.